This case is especially intriguing, as clinical features of NF1 were not recognized until the diagnosis of bilateral PCC was made at age 56 years, and in addition the patient developed primary prostate and lung cancers during his lifetime. The gene discussed is NF1; the disease is lung carcinoma.